175 related articles for article (PubMed ID: 29884842)
1. Identification of Ras-degrading small molecules that inhibit the transformation of colorectal cancer cells independent of β-catenin signaling.
Shin W; Lee SK; Hwang JH; Park JC; Cho YH; Ro EJ; Song Y; Seo HR; Choi KY
Exp Mol Med; 2018 Jun; 50(6):1-10. PubMed ID: 29884842
[TBL] [Abstract][Full Text] [Related]
2. A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab.
Lee SK; Cho YH; Cha PH; Yoon JS; Ro EJ; Jeong WJ; Park J; Kim H; Il Kim T; Min DS; Han G; Choi KY
Exp Mol Med; 2018 Nov; 50(11):1-12. PubMed ID: 30459318
[TBL] [Abstract][Full Text] [Related]
3. KY1022, a small molecule destabilizing Ras via targeting the Wnt/β-catenin pathway, inhibits development of metastatic colorectal cancer.
Cho YH; Cha PH; Kaduwal S; Park JC; Lee SK; Yoon JS; Shin W; Kim H; Ro EJ; Koo KH; Park KS; Han G; Choi KY
Oncotarget; 2016 Dec; 7(49):81727-81740. PubMed ID: 27835580
[TBL] [Abstract][Full Text] [Related]
4. β-Catenin-RAS interaction serves as a molecular switch for RAS degradation via GSK3β.
Lee SK; Jeong WJ; Cho YH; Cha PH; Yoon JS; Ro EJ; Choi S; Oh JM; Heo Y; Kim H; Min DS; Han G; Lee W; Choi KY
EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30413483
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the Wnt/β-catenin and RAS-ERK pathways involving co-stabilization of both β-catenin and RAS plays important roles in the colorectal tumorigenesis.
Lee SK; Hwang JH; Choi KY
Adv Biol Regul; 2018 May; 68():46-54. PubMed ID: 29449169
[TBL] [Abstract][Full Text] [Related]
6. Andrographolide sensitizes KRAS-mutant colorectal cancer cells to cetuximab by inhibiting the EGFR/AKT and PDGFRβ/AKT signaling pathways.
Liu YF; Feng ZQ; Chu TH; Yi B; Liu J; Yu H; Xue J; Wang YJ; Zhang CZ
Phytomedicine; 2024 Apr; 126():155462. PubMed ID: 38394734
[TBL] [Abstract][Full Text] [Related]
7. Small-molecule binding of the axin RGS domain promotes β-catenin and Ras degradation.
Cha PH; Cho YH; Lee SK; Lee J; Jeong WJ; Moon BS; Yun JH; Yang JS; Choi S; Yoon J; Kim HY; Kim MY; Kaduwal S; Lee W; Min do S; Kim H; Han G; Choi KY
Nat Chem Biol; 2016 Aug; 12(8):593-600. PubMed ID: 27294323
[TBL] [Abstract][Full Text] [Related]
8. Small Molecule Destabilizer of β-Catenin and Ras Proteins Antagonizes Growth of K-Ras Mutation-Driven Colorectal Cancers Resistant to EGFR Inhibitors.
Choi JK; Cho H; Moon BS
Target Oncol; 2020 Oct; 15(5):645-657. PubMed ID: 33026592
[TBL] [Abstract][Full Text] [Related]
9. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of aquaporin-5 sensitizes colorectal cancer cells to 5-fluorouracil via inhibition of the Wnt-β-catenin signaling pathway.
Li Q; Yang T; Li D; Ding F; Bai G; Wang W; Sun H
Biochem Cell Biol; 2018 Oct; 96(5):572-579. PubMed ID: 29390193
[TBL] [Abstract][Full Text] [Related]
11. Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer.
Ryu WJ; Lee JD; Park JC; Cha PH; Cho YH; Kim JY; Sohn JH; Paik S; Choi KY
Exp Mol Med; 2020 May; 52(5):832-842. PubMed ID: 32457491
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Wnt/β-catenin and RAS/ERK pathways provides a therapeutic strategy for gemcitabine-resistant pancreatic cancer.
Ryu WJ; Han G; Lee SH; Choi KY
Biochem Biophys Res Commun; 2021 Apr; 549():40-46. PubMed ID: 33662667
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
14. The anti-cancer activity of an andrographolide analogue functions through a GSK-3β-independent Wnt/β-catenin signaling pathway in colorectal cancer cells.
Reabroi S; Saeeng R; Boonmuen N; Kasemsuk T; Saengsawang W; Suksen K; Zhu W; Piyachaturawat P; Chairoungdua A
Sci Rep; 2018 May; 8(1):7924. PubMed ID: 29784906
[TBL] [Abstract][Full Text] [Related]
15. Small molecule-induced simultaneous destabilization of β-catenin and RAS is an effective molecular strategy to suppress stemness of colorectal cancer cells.
Cho YH; Ro EJ; Yoon JS; Kwak DK; Cho J; Kang DW; Lee HY; Choi KY
Cell Commun Signal; 2020 Mar; 18(1):38. PubMed ID: 32143715
[TBL] [Abstract][Full Text] [Related]
16. TGF-β acts as a dual regulator of COX-2/PGE
de Araújo WM; Tanaka MN; Lima PHS; de Moraes CF; Leve F; Bastos LG; Rocha MR; Robbs BK; Viola JPB; Morgado-Diaz JA
Cell Biol Int; 2021 Mar; 45(3):662-673. PubMed ID: 33300198
[TBL] [Abstract][Full Text] [Related]
17. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
[TBL] [Abstract][Full Text] [Related]
18. Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines.
Vitiello PP; Cardone C; Martini G; Ciardiello D; Belli V; Matrone N; Barra G; Napolitano S; Della Corte C; Turano M; Furia M; Troiani T; Morgillo F; De Vita F; Ciardiello F; Martinelli E
J Exp Clin Cancer Res; 2019 Jan; 38(1):41. PubMed ID: 30691487
[TBL] [Abstract][Full Text] [Related]
19. Identification of quinazoline compounds as novel potent inhibitors of Wnt/β-catenin signaling in colorectal cancer cells.
Li Y; Lu W; Saini SK; Moukha-Chafiq O; Pathak V; Ananthan S
Oncotarget; 2016 Mar; 7(10):11263-70. PubMed ID: 26820295
[TBL] [Abstract][Full Text] [Related]
20. All Trans-Retinoic Acid Mediates MED28/HMG Box-Containing Protein 1 (HBP1)/β-Catenin Signaling in Human Colorectal Cancer Cells.
Lee MF; Hsieh NT; Huang CY; Li CI
J Cell Physiol; 2016 Aug; 231(8):1796-803. PubMed ID: 26660958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]